Evidence map›Paper›PMID 37651187›Full record

ArticleThe Journal of clinical investigation2023

Theranostic gold-in-gold cage nanoparticles enable photothermal ablation and photoacoustic imaging in biofilm-associated infection models.

Maryam Hajfathalian, Christiaan R de Vries, Jessica C Hsu, Ahmad Amirshaghaghi, Yuxi C Dong, Zhi Ren, Yuan Liu, Yue Huang, Yong Li, Simon Ab Knight and 6 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Maryam HajfathalianDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Christiaan R de VriesDivision of Infectious Diseases, School of Medicine, Stanford University, Stanford, California, USA.
Jessica C HsuDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ahmad AmirshaghaghiDepartment of Bioengineering.
Yuxi C DongDepartment of Bioengineering.
Zhi RenDepartment of Orthodontics and Divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine, and.
Yuan LiuDepartment of Orthodontics and Divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine, and.
Yue HuangDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Yong LiDepartment of Orthodontics and Divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine, and.
Simon Ab KnightDepartment of Dermatology and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pallavi JonnalagaddaDepartment of Bioengineering.
Aimen ZlitniDepartment of Radiology, School of Medicine, Stanford University, Stanford, California, USA.
Elizabeth A GriceDepartment of Dermatology and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Paul L BollykyDivision of Infectious Diseases, School of Medicine, Stanford University, Stanford, California, USA.
Hyun KooDepartment of Orthodontics and Divisions of Pediatric Dentistry & Community Oral Health, School of Dental Medicine, and.
David P CormodeDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
University of Pennsylvania · USGovernment Dental College and Hospital · INStanford University · US

Funding

EMERGING INFECTIOUS DISEASEST32AI007502 · NIAID · STANFORD UNIVERSITY · PI Prasanna Jagannathan, DAVID A. RELMAN · 1995 to 2026
$6.8M
Biofilm Elimination and Caries Prevention using Multifunctional NanocatalystsR01DE025848 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI KOO, HYUN · 2017 to 2025
$5.6M
Biodegradable polymetal nanoparticle CT contrast agents for vascular imagingR01HL131557 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CORMODE, DAVID PETER · 2016 to 2020
$2.0M
Anti-biofilm laser-mediated photothermal ablation via complex noble metal nanostructuresK99EB028838 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI HAJFATHALIAN, MARYAM · 2020 to 2022
$248k
Immunization against Pf bacteriophage in Pseudomonas aeruginosa infectionK08AI151089 · NIAID · STANFORD UNIVERSITY · PI DE VRIES, CHRISTIAAN ROBERT · 2021 to 2021
$162k
NHLBI NIH HHS R01 HL131557NIAID NIH HHS K08 AI151089NIAID NIH HHS T32 AI007502NIBIB NIH HHS K99 EB028838NIDCR NIH HHS R01 DE025848
6 · The paper itself

Abstract

Biofilms are structured communities of microbial cells embedded in a self-produced matrix of extracellular polymeric substances. Biofilms are associated with many health issues in humans, including chronic wound infections and tooth decay. Current antimicrobials are often incapable of disrupting the polymeric biofilm matrix and reaching the bacteria within. Alternative approaches are needed. Here, we described a complex structure of a dextran-coated gold-in-gold cage nanoparticle that enabled photoacoustic and photothermal properties for biofilm detection and treatment. Activation of these nanoparticles with a near infrared laser could selectively detect and kill biofilm bacteria with precise spatial control and in a short timeframe. We observed a strong biocidal effect against both Streptococcus mutans and Staphylococcus aureus biofilms in mouse models of oral plaque and wound infections, respectively. These effects were over 100 times greater than those seen with chlorhexidine, a conventional antimicrobial agent. Moreover, this approach did not adversely affect surrounding tissues. We concluded that photothermal ablation using theranostic nanoparticles is a rapid, precise, and nontoxic method to detect and treat biofilm-associated infections.

Indexed as

NanoparticlesPhotoacoustic TechniquesWound InfectionAnimalsAnti-Bacterial AgentsBiofilmsGoldMicePrecision MedicineAnti-Bacterial AgentsGoldBacterial infectionsInfectious diseaseTherapeutics

Identifiers

PMID37651187
PMCPMC10617778
OpenAlexW4386325140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.